JAVELIN Solid Tumor: Safety and Clinical Activity of Avelumab (Anti-PD-L1) as First-Line Treatment in Patients with Advanced NSCLC
JOURNAL OF THORACIC ONCOLOGY（2017）
关键词
1L NSCLC,phase i,avelumab,PD-L1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要